Back

Title
  • en Application of POLARIC (TM) fluorophores in an in vivo tumor model
Creator
Accessrights open access
Subject
  • Other en tumor
  • Other en metastasis
  • Other en fluorescent probes
  • Other en in vivo imaging
  • NDC 497
Description
  • Abstract en Fluorescent and luminescent tools are commonly used to study the dynamics of cancer progression and metastases in real-time. Fluorophores have become essential tools to study biological events. However, few can sustain fluorescence long enough during long-term studies. In the present study, we focused on a series of new amphiphilic fluorophores known as POLARIC (TM), which emit strong fluorescence in lipid bilayers and can be readily modified using the Suzuki-Miyaura cross-coupling reaction. Appropriate chemical modifications of substituent groups can improve target-site specificity, reduce cytotoxicity and prolong emission. Therefore, in contrast to conventional fluorescent probes, these fluorophores show promise for long-term monitoring of biological processes. In the present study, we conducted long-term observations of tumor growth and metastasis using a POLARIC derivative as a novel fluorescent probe. For this purpose, we studied the metastatic melanoma cell line A375-SM, which proliferates at a high rate. We compared the characteristics of the POLARIC probe with the commercially available fluorescent dye PKH26 and fluorescent protein mRFP1. A375-SM cells were labeled with these fluorescent probes and orthotopically implanted into nude mice. The fluorescence emitted by POLARIC was detected more than five weeks after implantation without causing detectable harmful effects on tumor growth. By contrast, fluorescence of cells labeled with PKH26 could not be detected at this same time. Furthermore, POLARIC-, but not PKH26-labeled cells, were also detected in lung metastases. These results indicate that labeling cells with POLARIC fluorophores can significantly extend the time course of in vivo studies on tumor cell growth.
Publisher en Spandidos Publications
Date
    Issued2013-10
Language
  • eng
Resource Type journal article
Version Type VoR
Identifier HDL http://hdl.handle.net/2115/55294
Relation
  • isIdenticalTo DOI https://doi.org/10.3892/or.2013.2620
  • PMID 23877868
Journal
    • PISSN 1021-335X
    • EISSN 1791-2431
    • NCID AA11016405
      • en Oncology reports
      • Volume Number30 Issue Number4 Page Start1695 Page End1700
File
Oaidate 2023-07-26